• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: detection of the rare allele CYP2C19*4.

作者信息

Garcia-Barceló M, Chow L Y, Kum Chiu H F, Wing Y K, Shing Lee D T, Lam K L, Waye M M

机构信息

Psychiatry and Biochemistry, The Chinese University of Hong Kong, Hong Kong.

出版信息

Clin Chem. 1999 Dec;45(12):2273-4.

PMID:10585366
Abstract
摘要

相似文献

1
Frequencies of defective CYP2C19 alleles in a Hong Kong Chinese population: detection of the rare allele CYP2C19*4.
Clin Chem. 1999 Dec;45(12):2273-4.
2
S-mephenytoin hydroxylation phenotype and CYP2C19 genotype among Ethiopians.埃塞俄比亚人中S-美芬妥因羟基化表型与CYP2C19基因型
Pharmacogenetics. 1996 Dec;6(6):521-6. doi: 10.1097/00008571-199612000-00005.
3
CYP2C19 genotype and S-mephenytoin 4'-hydroxylation phenotype in a Chinese Dai population.中国傣族人群中CYP2C19基因型与S-美芬妥因4'-羟化代谢表型
Eur J Clin Pharmacol. 2002 Apr;58(1):15-8. doi: 10.1007/s00228-002-0425-x. Epub 2002 Feb 22.
4
Genetic variations of S-mephenytoin 4'-hydroxylase (CYP2C19) in the Chinese population.中国人群中S-美芬妥英4'-羟化酶（CYP2C19）的基因变异
Life Sci. 2000 Feb 25;66(14):PL175-81. doi: 10.1016/s0024-3205(00)00446-x.
5
Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.
Methods Enzymol. 1996;272:210-8. doi: 10.1016/s0076-6879(96)72025-6.
6
An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians.另一个缺陷等位基因CYP2C19*5导致了高加索人中S-美芬妥英代谢不良者的表型。
Pharmacogenetics. 1998 Apr;8(2):129-35. doi: 10.1097/00008571-199804000-00006.
7
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotype.与他们的CYP2C19基因类型相关，坦桑尼亚班图人代谢奥美拉唑和甲妥英的能力降低。
Clin Pharmacol Ther. 1998 Oct;64(4):391-401. doi: 10.1016/S0009-9236(98)90070-4.
8
A new genetic defect in human CYP2C19: mutation of the initiation codon is responsible for poor metabolism of S-mephenytoin.人类CYP2C19中的一种新的基因缺陷：起始密码子突变导致S-美芬妥英代谢不良。
J Pharmacol Exp Ther. 1998 Jan;284(1):356-61.
9
Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin.
J Pharmacol Exp Ther. 1998 Sep;286(3):1490-5.
10
Differences in the incidence of the CYP2C19 polymorphism affecting the S-mephenytoin phenotype in Chinese Han and Bai populations and identification of a new rare CYP2C19 mutant allele.中国汉族和白族人群中影响S-美芬妥英代谢表型的CYP2C19基因多态性发生率差异及一种新的罕见CYP2C19突变等位基因的鉴定
J Pharmacol Exp Ther. 1997 Apr;281(1):604-9.

引用本文的文献

1
Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.亚洲人群中他莫昔芬治疗的药物遗传学：从遗传多态性到临床结局。
Eur J Clin Pharmacol. 2021 Aug;77(8):1095-1111. doi: 10.1007/s00228-021-03088-y. Epub 2021 Jan 29.
2
The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.细胞色素P450 2C19基因多态性对伏立康唑体外代谢的影响。
Infect Drug Resist. 2018 Nov 1;11:2129-2135. doi: 10.2147/IDR.S179078. eCollection 2018.
3
Pharmacogenetic and clinical predictors of response to clopidogrel plus aspirin after acute coronary syndrome in Egyptians.
埃及人急性冠状动脉综合征后氯吡格雷联合阿司匹林反应的药物遗传学和临床预测因子。
Pharmacogenet Genomics. 2018 Sep;28(9):207-213. doi: 10.1097/FPC.0000000000000349.
4
Pharmacogenetics in Jewish populations.犹太人群中的药物遗传学。
Drug Metabol Drug Interact. 2014;29(4):221-33. doi: 10.1515/dmdi-2013-0069.
5
CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects.CYP2C19 基因型对健康中国男性受试者拉贝洛尔的药代动力学有重要影响。
Eur J Clin Pharmacol. 2013 Apr;69(4):799-806. doi: 10.1007/s00228-012-1428-x. Epub 2012 Oct 23.
6
Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.CYP2C19*4B 的鉴定：对药物代谢包括氯吡格雷反应性的遗传药理学意义。
Pharmacogenomics J. 2012 Aug;12(4):297-305. doi: 10.1038/tpj.2011.5. Epub 2011 Mar 1.
7
Pharmacogenetics of glucose-lowering drug treatment: a systematic review.降糖药物治疗的药物遗传学：一项系统评价。
Mol Diagn Ther. 2007;11(5):291-302. doi: 10.1007/BF03256250.
8
Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.哥伦比亚混血个体中CYP2C19的表型-基因型分析。
BMC Clin Pharmacol. 2007 Jul 11;7:6. doi: 10.1186/1472-6904-7-6.
9
Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.玻利维亚人群中CYP2C9和CYP2C19的基因多态性：一项调查与比较研究。
Eur J Clin Pharmacol. 2005 May;61(3):179-84. doi: 10.1007/s00228-004-0890-5. Epub 2005 Mar 18.
10
The effect of the CYP2C19 genotype on the hydroxylation index of omeprazole in South Indians.CYP2C19基因分型对南印度人奥美拉唑羟化指数的影响。
Eur J Clin Pharmacol. 2005 Mar;61(1):19-23. doi: 10.1007/s00228-004-0833-1. Epub 2005 Jan 21.